This report studies the Meningococcal Vaccine market, covering market size for segment by type (Quadrivalent, Bivalent, etc.), by application (Pneumonia, Meningitis, etc.), by Sales Channel (Direct Channel, Distribution Channel), by player (Novartis, GSK, Merck, CSL, Baxter, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Meningococcal Vaccine from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Meningococcal Vaccine market.

Also Read: http://www.marketwatch.com/story/meningococcal-vaccine-market-resea...

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-organic...

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Meningococcal Vaccine including:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-bathroo...

Market split by Type, can be divided into:
Quadrivalent
Bivalent
Others

Market split by Application, can be divided into:
Pneumonia
Meningitis
Bacteremia
Others

Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel

Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-worldwi...

Table of Contents

Chapter 1 Meningococcal Vaccine Market Overview
1.1 Meningococcal Vaccine Definition
1.2 Global Meningococcal Vaccine Market Size Status and Outlook (2015-2030)
1.3 Global Meningococcal Vaccine Market Size Comparison by Region (2015-2030)
1.4 Global Meningococcal Vaccine Market Size Comparison by Type (2015-2030)
1.5 Global Meningococcal Vaccine Market Size Comparison by Application (2015-2030)
1.6 Global Meningococcal Vaccine Market Size Comparison by Sales Channel (2015-2030)
1.7 Meningococcal Vaccine Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Meningococcal Vaccine Market Segment Analysis by Player
2.1 Global Meningococcal Vaccine Sales and Market Share by Player (2018-2020)
2.2 Global Meningococcal Vaccine Revenue and Market Share by Player (2018-2020)
2.3 Global Meningococcal Vaccine Average Price by Player (2018-2020)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Meningococcal Vaccine Market Segment Analysis by Type
3.1 Global Meningococcal Vaccine Market by Type
3.1.1 Quadrivalent
3.1.2 Bivalent
3.1.3 Others
3.2 Global Meningococcal Vaccine Sales and Market Share by Type (2015-2020)
3.3 Global Meningococcal Vaccine Revenue and Market Share by Type (2015-2020)
3.4 Global Meningococcal Vaccine Average Price by Type (2015-2020)
3.5 Leading Players of Meningococcal Vaccine by Type in 2020
3.6 Conclusion of Segment by Type

Also Read: http://www.marketwatch.com/story/june-2021-report-on-global-constan...
Chapter 4 Meningococcal Vaccine Market Segment Analysis by Application
4.1 Global Meningococcal Vaccine Market by Application
4.1.1 Pneumonia
4.1.2 Meningitis
4.1.3 Bacteremia
4.1.4 Others
4.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2015-2020)
4.3 Leading Consumers of Meningococcal Vaccine by Application in 2020
4.4 Conclusion of Segment by Application
Chapter 5 Meningococcal Vaccine Market Segment Analysis by Sales Channel
5.1 Global Meningococcal Vaccine Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Meningococcal Vaccine Revenue and Market Share by Sales Channel (2015-2020)
5.3 Leading Distributors/Dealers of Meningococcal Vaccine by Sales Channel in 2020
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Meningococcal Vaccine Market Segment Analysis by Region
6.1 Global Meningococcal Vaccine Market Size and CAGR by Region (2015-2030)
6.2 Global Meningococcal Vaccine Sales and Market Share by Region (2015-2020)
6.3 Global Meningococcal Vaccine Revenue and Market Share by Region (2015-2020)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Meningococcal Vaccine Market Share by Type
6.4.3 North America Meningococcal Vaccine Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Meningococcal Vaccine Market Share by Type
6.5.3 Europe Meningococcal Vaccine Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Meningococcal Vaccine Market Share by Type
6.6.3 Asia-Pacific Meningococcal Vaccine Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Meningococcal Vaccine Market Share by Type
6.7.3 South America Meningococcal Vaccine Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Meningococcal Vaccine Market Share by Type
6.8.3 Middle East & Africa Meningococcal Vaccine Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Meningococcal Vaccine Players
7.1 Novartis
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Novartis
7.2 GSK
7.3 Merck
7.4 CSL
7.5 Baxter
7.6 JN International Medical Corporation
7.7 Serum Institute of India
7.8 Bio-Med
7.9 China National Biotec Group
7.10 Hualan Bio
7.11 Walvax
7.12 Zhifei
Chapter 8 Upstream and Downstream Analysis of Meningococcal Vaccine
8.1 Industrial Chain of Meningococcal Vaccine
8.2 Upstream of Meningococcal Vaccine
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Meningococcal Vaccine
8.3.1 Leading Distributors/Dealers of Meningococcal Vaccine
8.3.2 Leading Consumers of Meningococcal Vaccine
Chapter 9 Development Trend of Meningococcal Vaccine (2021-2030)
9.1 Global Meningococcal Vaccine Market Size (Sales and Revenue) Forecast (2021-2030)
9.2 Global Meningococcal Vaccine Market Size and CAGR Forecast by Region (2021-2030)
9.3 Global Meningococcal Vaccine Market Size and CAGR Forecast by Type (2021-2030)
9.4 Global Meningococcal Vaccine Market Size and CAGR Forecast by Application (2021-2030)
9.5 Global Meningococcal Vaccine Market Size and CAGR Forecast by Sales Channel (2021-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

…….Continued

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105